Citi raised the firm’s price target on GE HealthCare (GEHC) to $89 from $86 and keeps a Buy rating on the shares. The firm adjusted targets in medical technology as part of a Q2 earnings preview.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare to present portfolio of precision care at SNMMI
- Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization
- GE Healthcare Issues $1.5 Billion in Senior Notes
- GE Healthcare Announces $1.5 Billion Notes Offering
- GE HealthCare announces NCCN Guidelines recommend use of FES PET imaging